SG11201609405VA - Carotenoid derivative, pharmaceutically acceptable salt thereof, and pharmaceutically acceptable ester or amide thereof - Google Patents
Carotenoid derivative, pharmaceutically acceptable salt thereof, and pharmaceutically acceptable ester or amide thereofInfo
- Publication number
- SG11201609405VA SG11201609405VA SG11201609405VA SG11201609405VA SG11201609405VA SG 11201609405V A SG11201609405V A SG 11201609405VA SG 11201609405V A SG11201609405V A SG 11201609405VA SG 11201609405V A SG11201609405V A SG 11201609405VA SG 11201609405V A SG11201609405V A SG 11201609405VA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutically acceptable
- amide
- carotenoid derivative
- acceptable salt
- ester
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 235000021466 carotenoid Nutrition 0.000 title 1
- 150000001747 carotenoids Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014104480 | 2014-05-20 | ||
JP2014247549 | 2014-12-08 | ||
PCT/JP2015/064408 WO2015178404A1 (fr) | 2014-05-20 | 2015-05-20 | Dérivé de caroténoïde, sel pharmaceutiquement acceptable de ce dernier et ester ou amide pharmaceutiquement acceptable de ce dernier |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201609405VA true SG11201609405VA (en) | 2016-12-29 |
Family
ID=54554071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201609405VA SG11201609405VA (en) | 2014-05-20 | 2015-05-20 | Carotenoid derivative, pharmaceutically acceptable salt thereof, and pharmaceutically acceptable ester or amide thereof |
Country Status (18)
Country | Link |
---|---|
US (1) | US10125104B2 (fr) |
EP (1) | EP3147279A4 (fr) |
JP (1) | JP6393754B2 (fr) |
KR (1) | KR101963946B1 (fr) |
CN (1) | CN106458881B (fr) |
AU (1) | AU2015262405B2 (fr) |
CA (1) | CA2948605C (fr) |
CL (1) | CL2016002940A1 (fr) |
HK (1) | HK1231459A1 (fr) |
IL (1) | IL248700B (fr) |
MX (1) | MX363918B (fr) |
NZ (1) | NZ726535A (fr) |
PH (1) | PH12016502303A1 (fr) |
RU (1) | RU2693455C2 (fr) |
SG (1) | SG11201609405VA (fr) |
TW (1) | TWI654171B (fr) |
WO (1) | WO2015178404A1 (fr) |
ZA (1) | ZA201607968B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105461696B (zh) * | 2015-12-08 | 2017-11-24 | 李秋菊 | 一种用于脑梗塞康复的药物组合物 |
JP2021008404A (ja) * | 2017-09-27 | 2021-01-28 | アスタファーマシューティカルズ株式会社 | 変形性関節症改善剤 |
JP2021028295A (ja) * | 2017-11-27 | 2021-02-25 | アスタファーマシューティカルズ株式会社 | 光学活性のトランス−アスタキサンチン誘導体又はその塩、及びそれらの化合物を含有する組成物 |
JP2021028301A (ja) * | 2017-12-04 | 2021-02-25 | アスタファーマシューティカルズ株式会社 | 皮膚炎治療剤 |
JP2021028300A (ja) * | 2017-12-04 | 2021-02-25 | アスタファーマシューティカルズ株式会社 | 掻痒抑制剤 |
JP2021054718A (ja) * | 2018-01-09 | 2021-04-08 | アスタファーマシューティカルズ株式会社 | ドライアイ改善剤 |
CN111727039A (zh) * | 2018-02-13 | 2020-09-29 | 阿斯塔制药有限公司 | 大肠炎改善剂 |
CN112367987A (zh) * | 2018-06-05 | 2021-02-12 | 旗舰创业创新五公司 | 活性剂和其用于治疗代谢障碍和非酒精性脂肪性肝病的方法 |
JP2021176821A (ja) * | 2018-08-01 | 2021-11-11 | アスタファーマシューティカルズ株式会社 | 新規カロテノイド関連誘導体、その塩又はエステル類若しくはアミド類 |
US20220380306A1 (en) * | 2019-09-27 | 2022-12-01 | Cardax,Inc. | Astaxanthin esters and methods of use thereof |
CN118084755A (zh) * | 2024-04-22 | 2024-05-28 | 潍坊富邦药业有限公司 | 一种高水溶性虾青素衍生物及制备方法 |
CN118063368A (zh) * | 2024-04-22 | 2024-05-24 | 潍坊富邦药业有限公司 | 一种水溶性虾青素衍生物及其合成方法 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100375740C (zh) | 2002-02-06 | 2008-03-19 | Dsmip资产公司 | 虾青素酯 |
US20080008798A1 (en) | 2002-02-06 | 2008-01-10 | Arnold Gloor | Salts of astaxathin esters |
EP1500645B1 (fr) | 2002-04-30 | 2009-07-15 | Suntory Holdings Limited | Esters d'acides gras a chaine moyenne astaxanthine, leur procede de production et composition renfermant ce ester |
US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
US20050004235A1 (en) | 2002-07-29 | 2005-01-06 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US20050059635A1 (en) | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
US20050143475A1 (en) | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
US20050148517A1 (en) | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
CN1708480B (zh) | 2002-07-29 | 2010-12-15 | 卡达克斯药物公司 | 用于抑制和改善疾病的类胡萝卜素结构类似物 |
US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050026874A1 (en) | 2002-07-29 | 2005-02-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease |
US20050009788A1 (en) | 2002-07-29 | 2005-01-13 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling connexin 43 expression |
US7375133B2 (en) | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050049248A1 (en) | 2002-07-29 | 2005-03-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for controlling C-reactive protein levels |
US7521584B2 (en) | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US20050059659A1 (en) | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for controlling C-reactive protein levels |
JP2006515516A (ja) * | 2003-01-09 | 2006-06-01 | ビーエーエスエフ アクチェンゲゼルシャフト | 遺伝子改変されたBlakeslea属の生物を使用する、カロチノイドまたはそれらの前駆体を製造するための方法、上記方法によって製造されたカロチノイドまたはそれらの前駆体、ならびにそれらの使用 |
EP1750723A1 (fr) * | 2004-04-14 | 2007-02-14 | Hawaii Biotech, Inc. | Analogues ou derives de carotenoide pour inhiber et reduire l'inflammation |
CA2606329A1 (fr) * | 2005-03-09 | 2006-09-21 | Cardax Pharmaceuticals, Inc. | Carotenoides, analogues de carotenoides ou derives de carotenoides permettant de traiter les troubles proliferatifs |
US20060270590A1 (en) * | 2005-03-29 | 2006-11-30 | Lockwood Samuel F | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
CA2613169A1 (fr) * | 2005-05-02 | 2006-11-09 | Cardax Pharmaceuticals, Inc. | Utilisation de carotenoides et/ou de derives/analogues de carotenoides dans la reduction/inhibition de certains effets negatifs des inhibiteurs de cox |
JP2007176814A (ja) * | 2005-12-27 | 2007-07-12 | Yoshihiro Futamura | 炎症性サイトカイン産生抑制作用を有するゼアキサンチン誘導体、それからなる食品製剤、化粧品、抗炎症剤 |
US20090099061A1 (en) | 2006-01-27 | 2009-04-16 | Foss Bente J | Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
JP2007238564A (ja) | 2006-03-10 | 2007-09-20 | Fujifilm Corp | カロチノイド−コラーゲンペプチド縮合体 |
WO2008023283A2 (fr) | 2006-08-25 | 2008-02-28 | Omnica Gmbh | Esters de lutéine stabilisés |
EP1952845A1 (fr) * | 2007-01-26 | 2008-08-06 | DSMIP Assets B.V. | Utilisation d'un dérivé d'astaxathine à des fins cosmétiques |
WO2008106606A2 (fr) * | 2007-02-28 | 2008-09-04 | Cardax Pharmaceuticals, Inc. | Analogues et dérivés de caroténoïdes dans le traitement du cancer de la prostate |
US8063101B2 (en) * | 2007-03-23 | 2011-11-22 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs and derivatives for the prevention of platelet aggregation |
CL2008002577A1 (es) | 2007-08-31 | 2009-10-23 | Basf Se | Procedimiento para preparar una solucion de un derivado de astaxantina en un aceite comestible que comprende suspender el derivado de astaxantina en aceite comestible cuyo diametro de particulas es de 0,5-50 um, donde el derivado de astaxantina comprende al menos un 70% en peso de al menos un compuesto de la formula (i). |
DK2403363T3 (da) | 2009-03-05 | 2013-03-18 | Basf Se | Formulering af Astaxanthin-derivater og anvendelse heraf II |
CN102340998B (zh) | 2009-03-05 | 2014-03-26 | 巴斯夫欧洲公司 | 虾青素衍生物的配制剂及其应用i |
CN102341006A (zh) | 2009-03-05 | 2012-02-01 | 巴斯夫欧洲公司 | 虾青素衍生物的粉状组合物ii |
EP2403360B1 (fr) | 2009-03-05 | 2016-08-10 | Basf Se | Formulation de dérivés d'astaxanthine et leur utilisation iii |
CN102341007A (zh) | 2009-03-05 | 2012-02-01 | 巴斯夫欧洲公司 | 生产虾青素衍生物的溶液的方法 |
DK2403359T3 (da) | 2009-03-05 | 2013-04-22 | Basf Se | Pulverformet sammensætning af astaxanthin-derivater I |
TWI501946B (zh) * | 2010-02-08 | 2015-10-01 | Basf Se | 蝦紅素二琥珀酸二甲酯之製造方法 |
MX2017003237A (es) | 2014-09-11 | 2017-06-29 | Basf Se | Metodo para producir esteres de astaxantina. |
-
2015
- 2015-05-20 NZ NZ726535A patent/NZ726535A/en not_active IP Right Cessation
- 2015-05-20 KR KR1020167032171A patent/KR101963946B1/ko active IP Right Grant
- 2015-05-20 TW TW104116160A patent/TWI654171B/zh not_active IP Right Cessation
- 2015-05-20 MX MX2016015236A patent/MX363918B/es active IP Right Grant
- 2015-05-20 JP JP2016521120A patent/JP6393754B2/ja active Active
- 2015-05-20 RU RU2016149777A patent/RU2693455C2/ru active
- 2015-05-20 US US15/312,111 patent/US10125104B2/en active Active
- 2015-05-20 AU AU2015262405A patent/AU2015262405B2/en not_active Ceased
- 2015-05-20 WO PCT/JP2015/064408 patent/WO2015178404A1/fr active Application Filing
- 2015-05-20 CA CA2948605A patent/CA2948605C/fr not_active Expired - Fee Related
- 2015-05-20 SG SG11201609405VA patent/SG11201609405VA/en unknown
- 2015-05-20 EP EP15795815.8A patent/EP3147279A4/fr not_active Withdrawn
- 2015-05-20 CN CN201580026006.9A patent/CN106458881B/zh not_active Expired - Fee Related
-
2016
- 2016-11-02 IL IL248700A patent/IL248700B/en active IP Right Grant
- 2016-11-17 ZA ZA2016/07968A patent/ZA201607968B/en unknown
- 2016-11-18 PH PH12016502303A patent/PH12016502303A1/en unknown
- 2016-11-18 CL CL2016002940A patent/CL2016002940A1/es unknown
-
2017
- 2017-05-18 HK HK17105022.2A patent/HK1231459A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2948605C (fr) | 2019-12-24 |
US20170081289A1 (en) | 2017-03-23 |
RU2693455C2 (ru) | 2019-07-03 |
NZ726535A (en) | 2019-02-22 |
MX2016015236A (es) | 2017-02-23 |
IL248700B (en) | 2019-06-30 |
IL248700A0 (en) | 2017-01-31 |
ZA201607968B (en) | 2018-05-30 |
RU2016149777A (ru) | 2018-06-21 |
WO2015178404A1 (fr) | 2015-11-26 |
MX363918B (es) | 2019-04-05 |
HK1231459A1 (zh) | 2017-12-22 |
RU2016149777A3 (fr) | 2018-12-28 |
KR101963946B1 (ko) | 2019-03-29 |
JP6393754B2 (ja) | 2018-09-19 |
EP3147279A1 (fr) | 2017-03-29 |
PH12016502303B1 (en) | 2017-02-13 |
TWI654171B (zh) | 2019-03-21 |
EP3147279A4 (fr) | 2018-01-10 |
JPWO2015178404A1 (ja) | 2017-04-20 |
TW201625521A (zh) | 2016-07-16 |
AU2015262405B2 (en) | 2019-01-03 |
KR20170007304A (ko) | 2017-01-18 |
CL2016002940A1 (es) | 2017-09-01 |
CA2948605A1 (fr) | 2015-11-26 |
PH12016502303A1 (en) | 2017-02-13 |
US10125104B2 (en) | 2018-11-13 |
CN106458881A (zh) | 2017-02-22 |
AU2015262405A1 (en) | 2016-12-08 |
CN106458881B (zh) | 2019-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1231459A1 (zh) | 類胡蘿蔔素衍生物、其藥學上可接受的鹽或者其藥學上可接受的酯類或酰胺類 | |
EP3099171A4 (fr) | Dérivés de dihydroptéridinone et leurs utilisations | |
EP3154972A4 (fr) | Dérivés d'azamophinan et leur utilisation | |
EP3195805A4 (fr) | Tête de stéthoscope et stéthoscope la comprenant | |
SG11201607045SA (en) | Pyrazole amide derivative | |
EP3177147A4 (fr) | Dérivés de dihydroptéridinone et leurs utilisations | |
ZA201607658B (en) | Carboxamide derivatives | |
EP3118211A4 (fr) | Composés amides et procédés de leur production et utilisation | |
IL256339B (en) | A derivative of pyrazole or its pharmacy salt | |
AP2016009554A0 (en) | Carboxamide derivatives | |
IL249356B (en) | A derivative of 2-acylaminothiazole or its salt | |
EP3130340A4 (fr) | Dérivé de l'isoactéoside, et procédé de préparation et utilisation de ce dernier | |
ZA201607919B (en) | Dipicolylamine derivatives and their pharmaceutical uses | |
EP3112343A4 (fr) | Derives amides | |
EP3176150A4 (fr) | Dérivé (acyle à chaîne moyenne)acide aminé basique | |
EP3187488A4 (fr) | Nouveau dérivé d'amino-phényl-sulfonyl-acétate et son utilisation | |
IL272366A (en) | Adamantylmethylamine derivatives and their uses as a pharmaceutical preparation | |
EP3244887A4 (fr) | 5-méthoxytryptophane et ses dérivés, et leurs utilisations | |
IL248801A0 (en) | Carboxamide history | |
EP3368509A4 (fr) | Dérivés amides fluorés et leurs utilisations comme agents thérapeutiques | |
EP3252038A4 (fr) | Dérivé de benzopyrroline-2-one substitué par groupe n-benzoate et son utilisation |